Navigation Links
AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007
Date:2/28/2008

, "Despite the challenges many companies have felt in this marketplace, AMICAS was able to grow bookings over 20 percent and enter into several very significant new customer partnerships in 2007. Several of the country's largest radiology groups made decisions to use AMICAS products as the basis for their automation infrastructure going forward. Also, one of the largest imaging center enterprises in the country, MedQuest Associates, made the strategic decision to use AMICAS technology as their standard platform for image and information management. In the fourth quarter of 2007, AMICAS was able to sign several very sophisticated and informed imaging service providers. We will work hard to help these new partners succeed and to make sure others follow in their footsteps. It is noteworthy that, despite obstacles such as the Deficit Reduction Act (DRA) and other reimbursement pressures, these groups made the decision to take their automation support to the next level with industry leading offerings from AMICAS."

Dr. Kahane went on to say, "While continuing to invest over 21 percent of our revenues in R&D costs and product enhancement purchases, AMICAS generated positive operating cash flow and ended the year with a strong cash and marketable securities balance, a strong recurring revenue base, and no debt. Everyone at AMICAS worked very hard to improve our operations and to help our customers and partners achieve their goals through the use of our innovative products and services. We believe that AMICAS is entering 2008 in a strong and very competitive position."

"As we have said before, AMICAS remains committed to becoming the leading independent image and information management solutions provider in the healthcare industry. Now more than ever, we believe that our innovative end- to-end suite of products, our strong and experienced team of professionals, and our dedicated focus on image and information management will help our customers and partners by e
'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call
2. AMICAS to Present at UBS Global Healthcare Services Conference
3. MedQuest Standardizes on AMICAS Vision Series PACS
4. AMICAS Solutions Closing the Loop in Radiology Communications
5. AMICAS Transforms Critical Results Notification with RadStream
6. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
7. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
8. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
9. AMICAS Schedules Third Quarter Earnings Call
10. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
11. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...esults of a 10-year study published in the August ...found that magnesium sulfate administered to women...he risk of cerebral palsy by 50 percent. The Benef...) trial was conducted in 18 centers in the U.S., i...renatal intervention ever found to reduce the inst...
(Date:8/29/2008)... http://www.aronowitzmd.com [Los An...espected experience in plastic surgery procedures ...consideration may be necessary for these patients,...e an established specialty of procedures for after...es, CA (PRWEB) August 29, 2008 -- Bariatric surger...
(Date:8/28/2008)...ues increase 138% versus Q2 2007 - Nine new Cen...RNewswire-FirstCall/ - CRH Medical Corporation,(CR... three and six months,ended June 30, 2008 (all fig...ths ended June 30, 2008 increased 138% to $1,653,8...7. Revenue for the six months ended June,30, 2008 ...
(Date:8/28/2008)...ion will be based in the Northeast region with mor...xt year, HARRISBURG, Pa., Aug. 28 /PRNewswire-USN...ity has hired a Patient Safety Liaison for the,Nor...eport to the,Pennsylvania Patient Safety Reporting...ylvania citizens., "Last year in focus groups wit...
Breaking Medicine News(10 mins):Health News:National study shows magensium sulfate reduces risk of cerebral palsy in premature births 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 2Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 3Health News:Dr. Joel Aronowitz, Specialist in Los Angeles Body Lift, Announces Plastic Surgery Options After Bariatric Surgery Weight Loss 4Health News:CRH Medical reports Q2 2008 results 2Health News:CRH Medical reports Q2 2008 results 3Health News:CRH Medical reports Q2 2008 results 4Health News:CRH Medical reports Q2 2008 results 5Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...s physically demanding - or who do shift work - co... A major study in the US showed that this heavy wo...ood pressure and underweight babies. Jobs which i...shift work and fatiguing work were also significan...
...the triptans are known to help counter the unpleas...re seven different triptan drugs available, it is ... the University of Netherlands have carried out a...on the triptans, covering over 18,000 patients. Th...
...it shows that warfarin and aspirin are equally eff...ients at risk. Aspirin prevents blood clotting by ...arfarin acts on the levels of blood clotting prote...s in the brain that lead to strokes. Till date, it...
...smallpox vaccine is being tested against cervical ...with 95% of cervical cancer cases, but not everyon...cer affects about 465,000 women worldwide each yea...d treated in its earliest stages there is a high s...
Other Medicine News:
(Date:8/28/2008)... VIENNA, Austria, Aug. 28 /- Inte...aborator Merck & Co., Inc. has initiated a Phase I...ne for the prevention of,Staphylococcus aureus (S....,placebo controlled study aims to evaluate the saf... patients with end-stage kidney disease on,hemodia...
(Date:8/27/2008)... - Patients in the VELCADE, melphalan and predn...nefit as well as a 30 percent complete response -,...nium: The Takeda,Oncology Company today announced ...andomized, Phase III VISTA(1) trial in this week,s...he results showed a significant survival,benefit a...
(Date:8/27/2008)... - First Phase 3 data, from BLISS-52 trial, e...trial, BLISS-76, expected by fall 2009 -, ROCKVIL...enome,Sciences, Inc. (Nasdaq: HGSI ) today announ... in BLISS-76, the second of two pivotal Phase 3,ra...umab) in patients with,active systemic lupus eryth...
(Date:8/26/2008)... INDIANAPOLIS, Aug. 26 /- Semafor...th International Congress on Targeted Therapies,in...ery of novel,multi-targeted kinase inhibitors that...eclinical studies., A novel and proprietary molec...al modeling allowing for the design of pan-PI3 kin...
Breaking Medicine Technology:Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 2Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Medicare Prescription Drug Benefit Nonprofit Hospitals Ambulatory Surgery Centers Statistical Methods and Pay For Performance Highlighted In the L 1162 1Medicare Prescription Drug Benefit Nonprofit Hospitals Ambulatory Surgery Centers Statistical Methods and Pay For Performance Highlighted In the L 1162 2Medicare Prescription Drug Benefit Nonprofit Hospitals Ambulatory Surgery Centers Statistical Methods and Pay For Performance Highlighted In the L 1162 3Spectranetics to Appeal Decision in Patent Litigation 1160 1Spectranetics to Appeal Decision in Patent Litigation 1160 2Spectranetics to Appeal Decision in Patent Litigation 1160 3Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year 552 1Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year 552 2ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference 550 1ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference 550 2
...lls Isolated from Females Regenerate Skeletal Musc...pril 09, 2007 /PRNewswire/ -- Female stem cells,de...rate skeletal,muscle tissue than male cells, accor...gh of UPMC. , The study, which is being published ...y, is the first ever to report a difference,in reg...
...y and MedImmune to Present Preclinical Data From S...IDGE, Mass. and GAITHERSBURG, Md., April 10, 2007 ... (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) t...with an oral formulation of IPI-504 in non-small,c...pcoming Annual,Meeting of the American Association...
Other Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
...clusive Measuring System delivers precise and accu...eel they are receiving a better examination when t...ipment. ,User Friendly - after only 5 minutes of...ome very proficient in the operation of this instr...
.90mm (20G) guillotine cutting probe with 1.4mm (17G) removable irrigation sleeve
Sleeve extends 3mm beyond end, .90mm (20G) probe, 1.4mm (17G) sleeve
Medicine Products: